181 related articles for article (PubMed ID: 25171093)
1. Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancers.
Peng J; Ding Y; Tu S; Shi D; Sun L; Li X; Wu H; Cai S
PLoS One; 2014; 9(8):e106344. PubMed ID: 25171093
[TBL] [Abstract][Full Text] [Related]
2. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.
Valentini V; van Stiphout RG; Lammering G; Gambacorta MA; Barba MC; Bebenek M; Bonnetain F; Bosset JF; Bujko K; Cionini L; Gerard JP; Rödel C; Sainato A; Sauer R; Minsky BD; Collette L; Lambin P
J Clin Oncol; 2011 Aug; 29(23):3163-72. PubMed ID: 21747092
[TBL] [Abstract][Full Text] [Related]
3. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.
van Gijn W; van Stiphout RGPM; van de Velde CJH; Valentini V; Lammering G; Gambacorta MA; Påhlman L; Bujko K; Lambin P
Ann Oncol; 2015 May; 26(5):928-935. PubMed ID: 25609247
[TBL] [Abstract][Full Text] [Related]
4. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
5. Validation of a rectal cancer outcome prediction model with a cohort of Chinese patients.
Shen L; van Soest J; Wang J; Yu J; Hu W; Gong YU; Valentini V; Xiao Y; Dekker A; Zhang Z
Oncotarget; 2015 Nov; 6(35):38327-35. PubMed ID: 26413811
[TBL] [Abstract][Full Text] [Related]
6. A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.
Sun Y; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
J Surg Oncol; 2017 Mar; 115(4):462-469. PubMed ID: 28105657
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of neoadjuvant rectal score-based signature nomograms to predict overall survival and disease-free survival in locally advanced rectal cancer: a retrospective, double center, cohort study.
Wang G; Tang Z; Ye J; Tang H; Yao K; Zeng Q; Yang Y; Fu M; Luo L; Shen Q; Fang X; Ling B; Fang Y; Guo Y; Huang Y
Int J Clin Oncol; 2023 Feb; 28(2):268-279. PubMed ID: 36534264
[TBL] [Abstract][Full Text] [Related]
8. Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy.
Wei FZ; Mei SW; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Liu Z; Liu Q
World J Gastroenterol; 2020 Nov; 26(42):6638-6657. PubMed ID: 33268952
[TBL] [Abstract][Full Text] [Related]
9. Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases.
Kusters M; Valentini V; Calvo FA; Krempien R; Nieuwenhuijzen GA; Martijn H; Doglietto GB; Del Valle E; Roeder F; Buchler MW; van de Velde CJH; Rutten HJT
Ann Oncol; 2010 Jun; 21(6):1279-1284. PubMed ID: 19889621
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatment may benefit patients with high-risk upper rectal cancer: A nomogram and recursive partitioning analysis of 547 patients.
Wang X; Jin J; Yang Y; Liu WY; Ren H; Feng YR; Xiao Q; Li N; Deng L; Fang H; Jing H; Lu NN; Tang Y; Wang JY; Wang SL; Wang WH; Song YW; Liu YP; Li YX
Oncotarget; 2016 Oct; 7(40):66160-66169. PubMed ID: 27449095
[TBL] [Abstract][Full Text] [Related]
11. Patterns and management of distant failure in locally advanced rectal cancer: a cohort study.
Arredondo J; Baixauli J; Rodríguez J; Beorlegui C; Arbea L; Zozaya G; Torre W; -Cienfuegos JA; Hernández-Lizoáin JL
Clin Transl Oncol; 2016 Sep; 18(9):909-14. PubMed ID: 26666769
[TBL] [Abstract][Full Text] [Related]
12. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.
Rose PG; Java J; Whitney CW; Stehman FB; Lanciano R; Thomas GM; DiSilvestro PA
J Clin Oncol; 2015 Jul; 33(19):2136-42. PubMed ID: 25732170
[TBL] [Abstract][Full Text] [Related]
13. Individualized conditional survival nomograms for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and radical surgery.
Zheng Z; Wang X; Liu Z; Lu X; Huang Y; Chi P
Eur J Surg Oncol; 2021 Dec; 47(12):3175-3181. PubMed ID: 34120806
[TBL] [Abstract][Full Text] [Related]
14. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
[TBL] [Abstract][Full Text] [Related]
15. Locally advanced rectal cancer: a multivariate analysis of outcome risk factors.
Bufalari A; Boselli C; Giustozzi G; Moggi L
J Surg Oncol; 2000 May; 74(1):2-10. PubMed ID: 10861600
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
[TBL] [Abstract][Full Text] [Related]
17. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study.
Seddik Y; Brahmi SA; Afqir S
Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979
[TBL] [Abstract][Full Text] [Related]
18. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.
Raut CP; Callegaro D; Miceli R; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss DC; Gonzalez R; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria S; Canter R; Mullen J; Gelderblom HJ; Pennacchioli E; van Coevorden F; Cardona K; Fiore M; Fairweather M; Gronchi A
Clin Cancer Res; 2019 Apr; 25(8):2664-2671. PubMed ID: 30723141
[TBL] [Abstract][Full Text] [Related]
19. Survival nomograms for stage III colorectal cancer.
Li C; Pei Q; Zhu H; Tan F; Zhou Z; Zhou Y; Li Y; Pei H
Medicine (Baltimore); 2018 Dec; 97(49):e13239. PubMed ID: 30544384
[TBL] [Abstract][Full Text] [Related]
20. Nomogram to predict disease recurrence in patients with locally advanced rectal cancer undergoing rectal surgery after neoadjuvant therapy: retrospective cohort study.
Saadoun JE; Meillat H; Zemmour C; Brunelle S; Lapeyre A; de Chaisemartin C; Lelong B
BJS Open; 2022 Nov; 6(6):. PubMed ID: 36515671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
